<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Microbiol.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">1664-302X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmicb.2025.1749456</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>(p)ppGpp mediates persister formation in <italic>Escherichia coli</italic> during glucose to fatty acid shift</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Ruixue</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1697143"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xiao</surname>
<given-names>Zhengyang</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Namburi</surname>
<given-names>Neha</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tang</surname>
<given-names>Yinjie</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/31810"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yuan</surname>
<given-names>Joshua</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/79171"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zhang</surname>
<given-names>Fuzhong</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/75549"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label><institution>Department of Energy, Environmental &#x0026; Chemical Engineering, Washington University in St. Louis</institution>, <city>St. Louis</city>, <state>MO</state>, <country country="us">United States</country></aff>
<aff id="aff2"><label>2</label><institution>Division of Biological and Biomedical Sciences, Washington University in St. Louis</institution>, <city>Saint Louis</city>, <state>MO</state>, <country country="us">United States</country></aff>
<aff id="aff3"><label>3</label><institution>Institute of Materials Science and Engineering, Washington University in St. Louis</institution>, <city>Saint Louis</city>, <state>MO</state>, <country country="us">United States</country></aff>
<author-notes>
<corresp id="c001"><label>&#x002A;</label>Correspondence: Fuzhong Zhang, <email xlink:href="mailto:fzhang@seas.wustl.edu">fzhang@seas.wustl.edu</email></corresp>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-01-16">
<day>16</day>
<month>01</month>
<year>2026</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2025</year>
</pub-date>
<volume>16</volume>
<elocation-id>1749456</elocation-id>
<history>
<date date-type="received">
<day>19</day>
<month>11</month>
<year>2025</year>
</date>
<date date-type="rev-recd">
<day>22</day>
<month>12</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>29</day>
<month>12</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2026 Zhang, Xiao, Namburi, Tang, Yuan and Zhang.</copyright-statement>
<copyright-year>2026</copyright-year>
<copyright-holder>Zhang, Xiao, Namburi, Tang, Yuan and Zhang</copyright-holder>
<license>
<ali:license_ref start_date="2026-01-16">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Bacterial persistence contributes to antibiotic failure and recurrent infectious disease, yet the metabolic cues that promote persister formation remain poorly understood. Here we investigated <italic>Escherichia coli</italic> persistence after nutrient downshifts from glucose to various carbons. Compared to shifts to gluconeogenic carbons (pyruvate, malate, succinate, and fumarate), the glucose-to-fatty acid shift induced exceptionally high persister levels, with cells tolerating ampicillin (56%), carbenicillin (22%), and gentamicin (1%) after 24-h treatment. With an RNA-based biosensor and HPLC quantification, we detected up to 4-fold higher guanosine tetra- and penta-phosphate [(p)ppGpp] during the prolonged carbon starvation period post glucose-to-fatty acid shift, whereas (p)ppGpp levels remained low after glucose-to-gluconeogenic carbon shifts due to the shorter lag phase. Shortening the lag phase by pre-exposing cells to fatty acid substantially reduced persistence after the glucose-to-fatty acid shift. Overexpression of acyl-ACP synthase, which acylates free acyl carrier protein and thereby suppresses SpoT-dependent (p)ppGpp synthesis, lowered (p)ppGpp levels and reduced persistence. Furthermore, overexpression of PlsB, a growth-essential enzyme in phospholipid biosynthesis that is inhibited by (p)ppGpp, also reduced persistence. In addition, <sup>13</sup>C isotope tracing and metabolomic analysis revealed that persisters remain metabolically adaptive, rerouting measurable carbon flux into gluconeogenesis and the pentose phosphate pathway for biomass synthesis. The metabolic remodeling could assist cells to balance redox homeostasis and mitigate oxidative stress. These findings establish the role of (p)ppGpp in nutrient shift persister formation and highlights critical pathways that may be targeted to reduce persistence and improve treatment outcomes against recurrent infections.</p>
</abstract>
<kwd-group>
<kwd>(p)ppGpp</kwd>
<kwd>bacterial persistence</kwd>
<kwd>nutrient shift</kwd>
<kwd>single-cell imaging</kwd>
<kwd>stress response</kwd>
</kwd-group>
<funding-group>
<funding-statement>The author(s) declared that financial support was received for this work and/or its publication. This work is supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number R35GM133797 and National Science Foundation under Award number 2320104.</funding-statement>
</funding-group>
<counts>
<fig-count count="4"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="61"/>
<page-count count="12"/>
<word-count count="8052"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Microbial Physiology and Metabolism</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="sec1">
<title>Introduction</title>
<p>Bacterial persister refers to a fraction of isogenic cells who are capable of surviving antibiotic treatment and regrowing once antibiotics are no longer present (<xref ref-type="bibr" rid="ref8">Balaban et al., 2004</xref>; <xref ref-type="bibr" rid="ref39">Lewis, 2007</xref>; <xref ref-type="bibr" rid="ref21">Fisher et al., 2017</xref>). Persisters have been identified across diverse pathogens, including bacteria, fungi, and parasites (<xref ref-type="bibr" rid="ref42">Niu et al., 2024</xref>; <xref ref-type="bibr" rid="ref58">Yuan et al., 2024</xref>). The reversible loss of antibiotic susceptibility in persister cells poses a critical clinical challenge, as it drives antibiotic therapy failure, recurrent infections, biofilm formation, and the potential evolution of genetic resistance (<xref ref-type="bibr" rid="ref2">Allison et al., 2011a</xref>; <xref ref-type="bibr" rid="ref13">Brauner et al., 2016</xref>; <xref ref-type="bibr" rid="ref7">Bakkeren et al., 2020</xref>). The global surge in chronic infectious and inflammatory diseases has underscored persisters as a major public health concern (<xref ref-type="bibr" rid="ref21">Fisher et al., 2017</xref>). Understanding and targeting persister cells represents a promising frontier for overcoming persistent infections, reducing relapse rates, and curbing the escalating crisis of antibiotic resistance.</p>
<p>Unlike antibiotic-resistant mutants, which evade drugs through genetic alterations, persister cells survive through distinct, reversible physiological alterations that allow them to tolerate lethal antibiotic (ABX) concentrations, such as by reducing drug uptake, preventing antibiotic-target interactions, or mitigating downstream lethal effects (<xref ref-type="bibr" rid="ref39">Lewis, 2007</xref>; <xref ref-type="bibr" rid="ref2">Allison et al., 2011a</xref>; <xref ref-type="bibr" rid="ref19">Fang and Allison, 2023</xref>). The elucidation of the molecular mechanisms driving bacterial persister formation is integral to understanding how these cells withstand antibiotic treatment. Extensive research has elucidated multiple molecular mechanisms underlying bacterial persister formation, including metabolic dormancy, DNA damage repair, stress response, cellular communication, efflux pump, and epigenetic modifications (<xref ref-type="bibr" rid="ref40">Moyed and Bertrand, 1983</xref>; <xref ref-type="bibr" rid="ref45">Spoering et al., 2006</xref>; <xref ref-type="bibr" rid="ref36">Kohanski et al., 2007</xref>; <xref ref-type="bibr" rid="ref52">Vega et al., 2012</xref>; <xref ref-type="bibr" rid="ref55">Wu et al., 2012</xref>; <xref ref-type="bibr" rid="ref35">Kim et al., 2022</xref>; <xref ref-type="bibr" rid="ref42">Niu et al., 2024</xref>; <xref ref-type="bibr" rid="ref50">Valencia et al., 2024</xref>). The existence of multiple, distinct pathways suggests persister formation is context-dependent and that each persister phenotype may follow its own unique route to persistence (<xref ref-type="bibr" rid="ref2">Allison et al., 2011a</xref>; <xref ref-type="bibr" rid="ref59">Zhang, 2014</xref>; <xref ref-type="bibr" rid="ref42">Niu et al., 2024</xref>).</p>
<p>In natural conditions, bacteria constantly face nutrient fluctuation, with the type, concentration, and availability of substrates vary greatly in the microenvironment (<xref ref-type="bibr" rid="ref15">Conway et al., 2004</xref>). Such nutrient changes could greatly alter bacterial metabolism, leading to systems level changes that affect many cellular processes, including persistence (<xref ref-type="bibr" rid="ref11">Biselli et al., 2020</xref>; <xref ref-type="bibr" rid="ref23">Gao et al., 2025</xref>). Unraveling the metabolic impacts during nutrient shifts may illustrate new persistence formation mechanism, leading to innovative approaches to prevent or eliminate persister cells in changing environments and effective infection control in clinical settings.</p>
<p>Previously, we reported an atypical tri-phasic antibiotic killing kinetics, characterized by a transient tolerance period, a rapid killing phase, and a slower persister killing phase when switching cells from a gluconeogenic carbon source to fatty acid (FA) supplemented with ampicillin (AMP). The transient tolerance right after nutrient shifts is caused by the time needed to accumulate FA degradation enzymes for sufficient carbon catabolism (<xref ref-type="bibr" rid="ref26">Hartline et al., 2022</xref>). During the subsequent FA catabolism, reactive oxygen species (ROS), likely induced by ampicillin, kill majority of cells (e.g., 99.99% after glycerol to oleic acid with ampicillin shift) through the secondary killing mechanism without cell lysis (<xref ref-type="bibr" rid="ref60">Zhang et al., 2024</xref>). In contrast, <italic>E. coli</italic> cells after a glucose (GLU) to oleic acid (OA) switch exhibited a high-level persistence to ampicillin (GLU&#x202F;&#x2192;&#x202F;OA&#x202F;+&#x202F;AMP, 56%) due to the lack of ROS accumulation. Yet it is unclear why cells were not killed by ampicillin nor grow in the presence of FA upon expression of FA degradation enzymes.</p>
<p>In this study, we investigated the persistence frequencies of <italic>E. coli</italic> cells during the nutrient downshift from glucose to various carbon sources. Time-lapse microscopy demonstrated that cells were killed through the ampicillin primary killing mechanism when switching from glucose to pyruvate, succinate, fumarate, and malate, except for the glucose to oleic acid switch. We observed that (p)ppGpp accumulation during the transient tolerance period inhibits cell growth, thereby promoting persistence. Additionally, we identified that (p)ppGpp mediates persister formation by inhibiting glycerol-3-phosphate 1-O-acyltransferase (encoded by <italic>plsB</italic>). The inhibitory process can be mitigated by overexpressing <italic>plsB</italic> or acyl-ACP synthetase (encoded by <italic>aas</italic>), which rebalance acyl-acp thus reducing (p)ppGpp concentration. Our findings confirmed the significant role of (p)ppGpp in regulating persister levels during nutrient downshift to OA and suggest potential therapeutic targets to combat bacterial persistence.</p>
</sec>
<sec sec-type="materials|methods" id="sec2">
<title>Materials and methods</title>
<sec id="sec3">
<title>Chemicals and materials</title>
<p>Phusion DNA polymerase, restriction enzymes, and T4 ligase used in plasmid construction were purchased from Thermo Fisher Scientific (Waltham, MA, United States). DNA-spin Plasmid DNA Purification Kit and MEGA quick-spin Total DNA Purification Kit were purchased from iNtRON Biotechnology (Burlington, MA, USA). Antibiotics and inducers were purchased from Gold Biotechnology, Inc. (St. Louis, MO, USA). PpGpp standard was purchased from Jena Biosciences (Jena, German). Other chemicals were purchased from Sigma-Aldrich (St. Louis, MO, USA).</p>
</sec>
<sec id="sec4">
<title>Bacterial strains, plasmids, and culture conditions</title>
<p>The <italic>E. coli</italic> K-12 strain NCM3722, sourced from the Coli Genetic Stock Center (Yale, USA), was employed as the wild-type strain. All strains and plasmids are listed in <xref rid="SM1" ref-type="supplementary-material">Supplementary Tables S1, S2</xref>, respectively. <italic>E. coli</italic> MDS42pdu strain was used for cloning. DNA Golden Gate Assembly and BglBrick (<xref ref-type="bibr" rid="ref38">Lee et al., 2011</xref>) were used for plasmid construction. Primers were designed by Benchling (San Francisco, CA, USA) and synthesized by Integrated DNA Technologies (Coralville, IA, USA).</p>
<p>The ppGpp RNA-based biosensor (pET-28c S2) was purchased from Addgene (plasmid #171920) and transformed into NCM3722 ybhC: T7 RNAP strain, which was made through inserting a T7 RNA polymerase expression cassette into the WT NCM3722 genome. Specifically, T7 RNA polymerase gene, LacI, LacI operator and Int 1 (T7-RNAP) were cloned from <italic>E. coli</italic> BL21(DE3) and was inserted into the ybhC gene site (<xref ref-type="bibr" rid="ref57">Ye et al., 2021</xref>) of NCM3722 according to the pTarget-pCas homologous recombination protocol as described previously (<xref ref-type="bibr" rid="ref31">Jiang et al., 2015</xref>, <xref ref-type="bibr" rid="ref32">2017</xref>). Colony PCR was used for mutant selection and the DNA fragment sequences were further confirmed by Sanger sequencing (South Plainfield, NJ, USA).</p>
<p>Genes encoding Aas, PlsB, and GFP were overexpressed from plasmids, which were constructed by inserting their PCR amplified DNA sequence into a low-copy number (SC101origin of replication), chloramphenicol resistant plasmid under the control of a LlacO-1 promoter (<xref ref-type="bibr" rid="ref38">Lee et al., 2011</xref>).</p>
<p>All strains were grown from single colonies and cultivated at 37 &#x00B0;C with 250&#x202F;rpm of shaking following previous protocols (<xref ref-type="bibr" rid="ref25">Hartline et al., 2020</xref>, <xref ref-type="bibr" rid="ref26">2022</xref>; <xref ref-type="bibr" rid="ref60">Zhang et al., 2024</xref>). Luria-Bertani (LB) media (10&#x202F;g NaCl, 10&#x202F;g Tryptone and 5&#x202F;g Yeast Extract) was used for cloning and amplifying population from single colony. M9 minimum media [75&#x202F;mM MOPS at pH 7.4, 2&#x202F;mM magnesium sulfate, 1&#x202F;mg/L thiamine hydrochloride, 10&#x202F;&#x03BC;M iron(II) sulfate, 100&#x202F;&#x03BC;M calcium chloride, 3&#x202F;&#x03BC;M ammonium heptamolybdate, 0.4&#x202F;mM boric acid, 30&#x202F;&#x03BC;M cobalt(II) chloride, 15&#x202F;&#x03BC;M copper(II) chloride, 80&#x202F;&#x03BC;M manganese(II) chloride, and 10&#x202F;&#x03BC;M zinc sulfate] supplemented with different carbon sources, such as glucose (12&#x202F;mM), oleic acid (4&#x202F;mM), malate (18&#x202F;mM), succinate (18&#x202F;mM), fumarate (18&#x202F;mM), or pyruvate (18&#x202F;mM), was used for persister assay. All cultures were supplemented with appropriate antibiotics (ampicillin, 100&#x202F;mg/L; kanamycin, 50&#x202F;mg/L; streptomycin, 100&#x202F;mg/L; chloramphenicol, 25&#x202F;&#x03BC;g/mL; carbenicillin, 100&#x202F;mg/L; gentamicin, 20&#x202F;mg/L).</p>
</sec>
<sec id="sec5">
<title>Nutrient shift persistence assay</title>
<p>Nutrient shift protocols were developed following previous methods (<xref ref-type="bibr" rid="ref37">Kotte et al., 2014</xref>; <xref ref-type="bibr" rid="ref26">Hartline et al., 2022</xref>; <xref ref-type="bibr" rid="ref60">Zhang et al., 2024</xref>). In brief, exponentially growing cells cultured in M9 glucose media were harvested by centrifugation (4,500&#x202F;&#x00D7;&#x202F;<italic>g</italic>, 10&#x202F;min, 4 &#x00B0;C) and washed three times with ice-cold carbon-free M9 media to remove pre-shift carbon completely. The cells were subsequently resuspended in M9 media, which was supplemented with oleic acid, fumarate, succinate, pyruvate, or malate, respectively, to an initial optical density (OD<sub>600</sub>) of 0.1&#x2013;0.2. The cell culture was challenged with appropriate antibiotics (ampicillin, 100&#x202F;mg/L; carbenicillin, 100&#x202F;mg/L; gentamicin, 20&#x202F;mg/L) immediately after the nutrient shift. At designated time points post-nutrient shift, 1&#x202F;mL aliquots were collected, centrifuged (4,500&#x202F;&#x00D7;&#x202F;<italic>g</italic>, 5&#x202F;min, 4 &#x00B0;C), and washed four times with ice-cold PBS (pH 7.4) to remove residual ampicillin. Cells were resuspended in PBS, serially diluted, and 5&#x202F;&#x03BC;L aliquots were plated onto LB agar plates. After overnight incubation at 37 &#x00B0;C, colonies were counted to determine the colony-forming units per milliliter of culture. For strains harboring gene overexpression plasmids, 1&#x202F;mM IPTG was added to the pre-shift M9 glucose culture at OD600&#x202F;&#x2248;&#x202F;0.1 and maintained throughout the assay. For NCM3722 yhbC:T7 RNAP cells carrying the ppGpp biosensor, 1&#x202F;mM IPTG was added 2&#x202F;h before the nutrient shift and maintained throughout the assay.</p>
</sec>
<sec id="sec6">
<title>Time lapse microscopy of antibiotic killing phase</title>
<p>Cell cultures were pelleted by centrifugation (6,500&#x202F;&#x00D7;&#x202F;<italic>g</italic>, 4 &#x00B0;C, 5&#x202F;min), washed, and resuspended in 10&#x202F;&#x03BC;L of M9 media containing ampicillin and the appropriate carbon source. Next, 1&#x202F;&#x03BC;L aliquot of the resuspended cells was transferred onto a 1% M9 agarose pad supplemented with ampicillin and the same carbon source, prepared according to <xref ref-type="bibr" rid="ref54">Wilmaerts et al. (2022)</xref>. The agarose pad was then sealed with a coverslip and incubated at 37 &#x00B0;C in a humid chamber (Tokai Hit, Incubation Systems for Microscopes, Japan) and imaged using a Nikon Eclipse Ti microscope (Nikon Instruments Inc., USA) equipped with an EMCCD camera (Photometrics Inc., Huntington Beach, CA, USA) and a 100&#x00D7;, NA 1.40, oil-immersion phase-contrast objective lens. An X-Cite 120 LED was used as the light source. Time-lapse images were acquired every 5&#x202F;min by an automated scanning function of the microscope with a built-in perfect focus system.</p>
</sec>
<sec id="sec7">
<title>Single cell (p)ppGpp imaging and analysis</title>
<p>To quantify ppGpp using the biosensor, 200&#x202F;&#x03BC;M of DFHBI-1&#x202F;T was added to 1&#x202F;mL of cell culture, followed by incubation in the dark at room temperature for 30&#x202F;min. Cells were then pelleted by centrifugation (6,500&#x202F;&#x00D7;&#x202F;<italic>g</italic>, 5&#x202F;min) and resuspended in 10&#x202F;&#x03BC;L 1x PBS. A 1&#x202F;&#x03BC;L aliquot of the resuspended cells was used for imaging. Images were acquired using microscope as mentioned above with a FITC (&#x03BB;<sub>ex</sub>&#x202F;=&#x202F;480&#x202F;&#x00B1;&#x202F;30&#x202F;nm, &#x03BB;<sub>em</sub>&#x202F;=&#x202F;510&#x202F;&#x00B1;&#x202F;10&#x202F;nm, Nikon Instruments Inc., USA) filter cube for spectral separation. More than 300 single cells per sample were collected and analyzed using the Nikon NIS-Elements software package following previous methods (<xref ref-type="bibr" rid="ref24">Han and Zhang, 2020</xref>).</p>
</sec>
<sec id="sec8">
<title>(p)ppGpp quantification with HPLC</title>
<p>ppGpp quantification was performed as described before (<xref ref-type="bibr" rid="ref43">Radzikowski et al., 2016</xref>) with slight modifications. At least 2&#x202F;&#x00D7;&#x202F;10<sup>10</sup> cells were harvested by centrifugation (10,000&#x202F;&#x00D7;&#x202F;<italic>g</italic>, 4 &#x00B0;C, 1&#x202F;min), and cell pellet was immediately resuspended in 3&#x202F;mL of 1&#x202F;M ice-cold formic acid. Samples were then incubated at 0 &#x00B0;C for 60&#x202F;min with intermittent vertexing. Following incubation, the suspension was centrifuged (21,000 <italic>g</italic>, 4 &#x00B0;C, 1&#x202F;min) and the supernatant was transferred to a new tube and flash-frozen in liquid nitrogen. Water and formic acid were removed by freeze-drying overnight. The dried metabolites were resuspended in 0.13&#x202F;mL of 0.1 M formic acid by vertexing and ultrasonication, then filtered by centrifugation (21,000&#x202F;&#x00D7;&#x202F;<italic>g</italic>, 4 &#x00B0;C, 1&#x202F;min) through a Spin-X centrifuge filter (Corning, 0.22-&#x03BC;m nylon membrane, 4,000&#x202F;<italic>g</italic>). Samples were analyzed using an Agilent 1,260 HPLC system equipped with a multi-wavelength detector (MWD) monitoring absorbance at 260&#x202F;nm. A PL-SAX anion exchange column (10&#x202F;&#x03BC;m, 150&#x202F;&#x00D7;&#x202F;4.6&#x202F;mm, 1,000&#x00C5;, Agilent) was used at a column temperature of 60 &#x00B0;C. A 35-minuate linear gradient of two solvents was applied, changing from Buffer A (0.01&#x202F;M K<sub>2</sub>HPO<sub>4</sub>, pH 2.6) to Buffer B (0.5&#x202F;M K<sub>2</sub>HPO<sub>4</sub>, pH 3.5) in 30&#x202F;min, using a flow rate of 1&#x202F;mL/min. Peak areas were quantified using a ppGpp standard curve prepared in 0.1 M formic acid. Intracellular concentrations were calculated based on the number of cells harvested and cell volume (<xref ref-type="bibr" rid="ref53">Volkmer and Heinemann, 2011</xref>).</p>
</sec>
<sec id="sec9">
<title><sup>13</sup>C-labeling of proteinogenic amino acid</title>
<p>Following a nutrient shift from <sup>12</sup>C-glucose to ampicillin-containing <sup>13</sup>C-Oleic acid, samples were collected at 5, 9, and 24&#x202F;h post shift. At least 2&#x202F;&#x00D7;&#x202F;10<sup>10</sup> cells were added to pre-chilled 0.9% (wt/vol) NaCl solution (1:1 volume ratio) to quench the metabolism. Cells were then pelleted by centrifugation (8,000&#x202F;<italic>g</italic> at 4 &#x00B0;C, 10&#x202F;min), and the pellet was resuspended in 1.5&#x202F;mL of 6&#x202F;M HCl and hydrolyzed at 100 &#x00B0;C for 20&#x202F;h. The hydrolysates were then transferred to microcentrifuge tubes, and debris was removed by centrifugation (20,000&#x202F;&#x00D7;&#x202F;<italic>g</italic>, 5&#x202F;min). Amino acids were derivatized the by adding 300&#x202F;&#x03BC;L of tetrahydrofuran (THF) and TBDMS (1:1, vol/vol), followed by incubation at 70 &#x00B0;C for 1&#x202F;h. Samples were analyzed with GC&#x2013;MS after removing the debris with centrifugation and data was processed as described previously (<xref ref-type="bibr" rid="ref28">Hollinshead et al., 2019</xref>; <xref ref-type="bibr" rid="ref47">Sun et al., 2025</xref>).</p>
</sec>
<sec id="sec10">
<title>Relative metabolite abundance analysis</title>
<p>After performing a GLU&#x202F;&#x2192;&#x202F;OA&#x202F;+&#x202F;AMP shift, samples were collected at 5, 9, and 24&#x202F;h post shift. Cells exponentially growing in M9 <sup>13</sup>C-glucose media were collected as reference. At least 2&#x202F;&#x00D7;&#x202F;10<sup>10</sup> cells were collected and added to pre-chilled 0.9% (wt/vol) NaCl solution (1:1, vol/vol) to quench metabolism. Cell pellet was then collected by centrifugation at 5,000&#x202F;&#x00D7;&#x202F;<italic>g</italic>, 0 &#x00B0;C for 3&#x202F;min, and then resuspended in 750&#x202F;&#x03BC;L methanol-chloroform solution (volume ratio 1:1). Experimental samples after the nutrient shift were combined with reference sample (cells exponentially growing in M9 <sup>13</sup>C-glucose) and then incubated at 4 &#x00B0;C with shaking at 250&#x202F;rpm for 4&#x202F;h. After incubation, 500&#x202F;&#x03BC;L of ice-cold HPLC grade water was added, and the mixture was vortexed for 2&#x202F;min. The mixture was then centrifuged at 600&#x202F;&#x00D7;&#x202F;<italic>g</italic> for 8&#x202F;min at &#x2212;10 &#x00B0;C to allow phase separation. The aqueous phase was carefully transferred to a clean tube and filtered using a 3&#x202F;kDa cut-off centrifugal filter (21,000&#x202F;&#x00D7;&#x202F;<italic>g</italic>, &#x2212;10 &#x00B0;C, 90&#x202F;min). The filtrate was frozen in liquid nitrogen and freeze-dried. Dried metabolites were resuspended in 100&#x202F;&#x03BC;L of methanol-chloroform (1:1, vol/vol) and analyzed with LC&#x2013;MS as previously described (<xref ref-type="bibr" rid="ref29">Hollinshead et al., 2016</xref>, <xref ref-type="bibr" rid="ref28">2019</xref>).</p>
</sec>
<sec id="sec11">
<title>Statistical analysis</title>
<p>Statistical analysis was conducted using GraphPad Prism. The data utilized originate from at least three biological replicates, where applicable. Statistical outcomes are denoted by asterisks (&#x002A;<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05, &#x002A;&#x002A;<italic>p</italic>&#x202F;&#x003C;&#x202F;0.01, &#x002A;&#x002A;&#x002A;<italic>p</italic>&#x202F;&#x003C;&#x202F;0.001, &#x002A;&#x002A;&#x002A;&#x002A;<italic>p</italic>&#x202F;&#x003C;&#x202F;0.0001), indicating significant results, or by the absence of asterisks (non-significant).</p>
</sec>
</sec>
<sec sec-type="results" id="sec12">
<title>Results</title>
<sec id="sec13">
<title>Nutrient downshift from glucose to oleic acid uniquely promotes persistence</title>
<p>Cells demonstrate remarkable metabolic plasticity, allowing them to efficiently use a wide range of metabolic substrates and adapt to changing environmental conditions. This adaptability is essential for their survival and sustained function (<xref ref-type="bibr" rid="ref14">Cabodevilla et al., 2013</xref>). Following a GLU&#x202F;&#x2192;&#x202F;OA&#x202F;+&#x202F;AMP switch, 56% of cells survived 24-h of ampicillin treatment (<xref ref-type="bibr" rid="ref26">Hartline et al., 2022</xref>; <xref ref-type="bibr" rid="ref60">Zhang et al., 2024</xref>). We first assessed whether this high persistence level is unique to the GLU&#x202F;&#x2192;&#x202F;OA&#x202F;+&#x202F;AMP switch or can be triggered by a nutrient shift from glucose to other gluconeogenic carbon sources in the presence of ampicillin. We selected pyruvate (PYR), malate (MAL), fumarate (FUM), and succinate (SUC) for nutrient shift persister assays, as these carbons represent different entry points into glycolysis and the TCA cycle. Cells at designated time points after nutrient shift were collected, washed and plated on antibiotic-free plates to determine survivor counts and generate time-kill curves (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Unlike GLU&#x202F;&#x2192;&#x202F;OA&#x202F;+&#x202F;AMP shift, glucose shifts to all four tested gluconeogenic carbons exhibited normal cell killing dynamics, with persistence levels ranging from 10<sup>&#x2212;6</sup> to10<sup>&#x2212;7</sup> (<xref ref-type="fig" rid="fig1">Figure 1B</xref>), consistent with wild-type (WT) <italic>E. coli</italic> persistence levels in exponentially growing cell cultures (<xref ref-type="bibr" rid="ref51">V&#x00E1;zquez-Laslop et al., 2006</xref>). Additionally, these shifts did not induce notable transient tolerance, suggesting <italic>E. coli</italic> resumed growth quickly after switching without the extended lag phase as observed during a shift to OA (<xref rid="SM1" ref-type="supplementary-material">Supplementary Figure S1</xref>).</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption>
<p>Nutrient downshift from glucose to oleic acid promotes persistence. <bold>(A)</bold> Illustration of nutrient shift persister assay experimental protocol. <bold>(B)</bold> Time&#x2013;kill curves of <italic>Escherichia coli</italic> after nutrient downshift from M9 glucose to ampicillin containing M9 with different carbon source media. <bold>(C)</bold> Comparison of persister level at 24&#x202F;h after nutrient downshift from M9 glucose to antibiotic containing M9 with different carbon media. Statistical results in <bold>(B,C)</bold> were calculated using a one-way ANOVA method with Dunnett&#x2019;s test of 24&#x202F;h survival rates. For each antibiotic tested in <bold>(C)</bold>, the persister levels of GLU&#x202F;&#x2192;&#x202F;MAL, GLU&#x202F;&#x2192;&#x202F;PYR, GLU&#x202F;&#x2192;&#x202F;FUM, and GLU&#x202F;&#x2192;&#x202F;SUC were compared with GLU&#x202F;&#x2192;&#x202F;OA. Statistical results indicating significant differences from GLU&#x202F;&#x2192;&#x202F;OA were labeled. <bold>(D)</bold> Time-lapse images of cells during ampicillin treatment period after nutrient downshift from M9 glucose to oleic acid (top) and M9 fumarate (bottom).</p>
</caption>
<graphic xlink:href="fmicb-16-1749456-g001.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Diagram illustrating a bacterial growth experiment. Panel A shows a workflow involving centrifuging and washing bacteria, then removing antibiotics for CFU counting. Panel B presents a line graph of log fold survival over time for different carbon sources. Panel C features a bar chart comparing log fold survival with various antibiotics. Panel D includes microscopy images showing bacterial growth over time on agarose pads with different carbon sources, labeled with timestamps.</alt-text>
</graphic>
</fig>
<p>To test whether the elevated persistence level after GLU&#x202F;&#x2192;&#x202F;OA&#x202F;+&#x202F;AMP switch is specific to ampicillin, we performed the nutrient shifts and time-kill experiments using an alternative beta-lactam antibiotic, carbenicillin (CRB), or an aminoglycoside, gentamicin (GEN). For both CRB and GEN, high levels of persistence (&#x003E;1% persisters at 24&#x202F;h post-shift) were only observed after GLU&#x202F;&#x2192;&#x202F;OA&#x202F;+&#x202F;ABX shift, not with other gluconeogenic carbon shifts (<xref ref-type="fig" rid="fig1">Figure 1C</xref>), indicating this effect is specific to the GLU&#x202F;&#x2192;&#x202F;OA&#x202F;+&#x202F;ABX condition.</p>
<p>The unique high persistence makes the GLU&#x202F;&#x2192;&#x202F;OA&#x202F;+&#x202F;ABX shifts a compelling model to study how metabolism drives persister formation. We focused on ampicillin due to its characteristic lysis-based killing, which can be readily visualized under the microscope. Time-lapse microscopy was used to monitor cell morphological changes post nutrient shifts. After shifting from glucose to pyruvate, succinate, malate, or fumarate, cells lysed in the presence of ampicillin as indicated by sudden disruptions in cell outlines (<xref rid="SM1" ref-type="supplementary-material">Supplementary Videos S1&#x2013;S4</xref>). Cell lysis typically occurred within 1&#x2013;4&#x202F;h post-shift, consistent with the time-kill data. Cell lysis in the presence of ampicillin is also consistent with the primary killing mechanism: inhibition of peptidoglycan biosynthesis weakens bacterial cell wall, making it unable to withstand the internal pressure (<xref ref-type="bibr" rid="ref33">Kawai et al., 2023</xref>). In contrast, cells after the GLU&#x202F;&#x2192;&#x202F;OA&#x202F;+&#x202F;AMP shift remained intact without lysis throughout the 24-h ampicillin treatment, indicating ampicillin failed to weaken bacterial cell walls (<xref ref-type="fig" rid="fig1">Figure 1D</xref>; <xref rid="SM1" ref-type="supplementary-material">Supplementary Video S5</xref>).</p>
</sec>
<sec id="sec14">
<title>Glucose-to-oleic acid downshift triggers ppGpp-dependent persistence</title>
<p>Glucose is the preferred carbon source for <italic>E. coli</italic>. Previous studies have shown that shifting cells from a preferred to a less preferred carbon source can trigger the stringent response, mediated by the signaling molecules guanosine tetra- and penta-phosphate, collectively known as (p)ppGpp (referred to here as ppGpp) (<xref ref-type="bibr" rid="ref1">Ahn-Horst et al., 2022</xref>; <xref ref-type="bibr" rid="ref61">Zhu and Dai, 2023</xref>). Accumulation of ppGpp downregulates multiple growth-related processes and upregulates stress response pathways. Under extreme conditions, ppGpp promotes dormancy and enhances persistence level (<xref ref-type="bibr" rid="ref5">Amato et al., 2013</xref>; <xref ref-type="bibr" rid="ref37">Kotte et al., 2014</xref>; <xref ref-type="bibr" rid="ref4">Amato and Brynildsen, 2015</xref>; <xref ref-type="bibr" rid="ref43">Radzikowski et al., 2016</xref>). Given this role, we investigated whether the high persistence observed after the GLU&#x202F;&#x2192;&#x202F;OA&#x202F;+&#x202F;AMP downshift is associated with elevated ppGpp level.</p>
<p>We used an RNA-based ppGpp biosensor developed by <xref ref-type="bibr" rid="ref48">Sun et al. (2021)</xref> to measure ppGpp levels in single cells following nutrient shifts. The biosensor comprises a ppGpp-specific aptamer, a transducer sequence, and a fluorogenic RNA reporter. Upon ppGpp binding, the transducer promotes hybridization that enables the RNA reporter to bind its cognate dye, DFHBI-1T, activating fluorescence. We transformed <italic>E. coli</italic> with the ppGpp biosensor and kept the RNA constitutively transcribed while cultivating the cells in either a steady state growing phase in M9 glucose media or subjected to nutrient shifts to M9 OA media supplemented with ampicillin.</p>
<p>Cells grown on glucose displayed weak green fluorescence, establishing the baseline ppGpp level (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). At 30&#x202F;min after the GLU&#x202F;&#x2192;&#x202F;OA&#x202F;+&#x202F;AMP shift, fluorescence was slightly higher but not statistically different from the glucose control. However, by 3&#x202F;h, a subpopulation of cells exhibited a substantial increase in fluorescence intensity and lasted through 6&#x202F;h post-shift, indicating elevated ppGpp levels (<xref ref-type="fig" rid="fig2">Figures 2A</xref>,<xref ref-type="fig" rid="fig2">B</xref>). This increase coincided with the transient tolerance period observed in earlier persistence assays (<xref ref-type="fig" rid="fig1">Figure 1B</xref>) and is likely due to impaired FA utilization, potentially caused by limited FA degradation enzymes (<xref ref-type="bibr" rid="ref60">Zhang et al., 2024</xref>). The presence of high-fluorescence cells supports a potential role for ppGpp in persistence formation.</p>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption>
<p>Glucose-to-oleic acid downshift triggers ppGpp-dependent persistence. <bold>(A)</bold> Microscopy images of cells carrying the RNA-based ppGpp biosensor at different stages during a glucose to ampicillin containing oleic acid shift. <bold>(B)</bold> Relative ppGpp intensity in single cells (<italic>n</italic>&#x003E;300 from biological triplicates) at different time points after the nutrient shift from glucose to ampicillin-containing oleic acid. <italic>p</italic> values were calculated using a pairwise comparison method with Holm-Sidak&#x2019;s test. Intracellular ppGpp level quantified with HPLC at different time points of nutrient downshift from glucose to ampicillin-containing oleic acid <bold>(C)</bold>, succinate <bold>(D)</bold>, malate <bold>(E)</bold>, pyruvate <bold>(F)</bold>, and fumarate <bold>(G)</bold>. Statistical results in <bold>(C&#x2013;G)</bold> were calculated using a one-way ANOVA method with Dunnett&#x2019;s test.</p>
</caption>
<graphic xlink:href="fmicb-16-1749456-g002.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Panel A shows a series of microscopic images divided into two rows, illustrating bacterial culture changes over time under different conditions. The top row displays grayscale images, and the bottom row shows fluorescence marking specific cells. Panels B to G present bar and dot plots depicting ppGpp intensity and concentration in various experimental setups, examining the impact of different compounds on bacterial cultures. Time points and statistical significance are indicated, demonstrating changes in ppGpp levels under specific conditions such as OA with AMP and Suc with AMP.</alt-text>
</graphic>
</fig>
<p>To further confirm ppGpp accumulation dynamics, we also quantified the population-average intracellular ppGpp levels using HPLC, following published methods (<xref ref-type="bibr" rid="ref43">Radzikowski et al., 2016</xref>). The standard curve and chromatograms are presented in <xref rid="SM1" ref-type="supplementary-material">Supplementary Figure S2</xref>. The population level ppGpp change closely mirrored biosensor results (<xref ref-type="fig" rid="fig2">Figure 2C</xref>), showing an approximately 3-fold increase at 3&#x202F;h followed by a slight decline at 6&#x202F;h. In contrast, no significant ppGpp elevation was observed after shifting glucose to other gluconeogenic carbon sources (<xref ref-type="fig" rid="fig2">Figures 2D</xref>&#x2013;<xref ref-type="fig" rid="fig2">G</xref>). Instead, ppGpp levels steadily declined, likely due to cell death post-shift. Collectively, these findings confirm that ppGpp accumulates following the GLU&#x202F;&#x2192;&#x202F;OA&#x202F;+&#x202F;AMP shift. Its accumulation kinetics and heterogeneity exhibiting a striking resemblance to the observations from time-kill survival kinetics.</p>
</sec>
<sec id="sec15">
<title>ppGpp mediates higher persistence via inhibiting phospholipid synthesis</title>
<p>We next aimed to dissect the molecular mechanisms linking ppGpp to persistence during the GLU&#x202F;&#x2192;&#x202F;OA&#x202F;+&#x202F;AMP shift. Previous studies have shown that ppGpp inhibits bacterial growth-related processes in a concentration-dependent and sequential manner, with different pathways requiring distinct ppGpp levels for inhibition (<xref ref-type="bibr" rid="ref9">Balsalobre, 2011</xref>; <xref ref-type="bibr" rid="ref46">Steinchen et al., 2020</xref>; <xref ref-type="bibr" rid="ref16">Czech et al., 2022</xref>). Thus, the specific ppGpp-triggered growth-inhibition mechanism may be condition-dependent.</p>
<p>We first hypothesized that the elevated ppGpp level was triggered by carbon starvation. When growing <italic>E. coli</italic> in glucose media, FA degradation pathway is tightly repressed by catabolic repression. After the GLU&#x202F;&#x2192;&#x202F;OA&#x202F;+&#x202F;AMP shift, cells require up to 6&#x202F;h to fully express FA degradation enzymes (<xref ref-type="bibr" rid="ref60">Zhang et al., 2024</xref>), creating an extended starvation period during the lag phase. This prolonged starvation does not occur when cells are shifted from glucose to other gluconeogenic carbons (<xref rid="SM1" ref-type="supplementary-material">Supplementary Figure S1</xref>). We hypothesized that shortening the starvation period might reduce ppGpp-triggered persister formation. To test this, cells were pre-grown in M9 OA media to fully induce FA degradation enzymes, then transferred to M9 glucose for 1 or 2 generations, corresponding to 1/2 or 1/4 dilution of FA degradation enzyme levels. We then performed the GLU&#x202F;&#x2192;&#x202F;OA&#x202F;+&#x202F;AMP nutrient shift and time-kill assay (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). The results revealed that cells grown in glucose for 1 generation retained sufficient FA degradation capacities to immediately metabolize OA, resulting in rapid killing of 99.99% of cells (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). In contrast, cells grown in glucose for two generations exhibited a up to 3-h transient tolerance period following the shift due to insufficient initial FA degradation enzymes. FA catabolism subsequently resumed, leading to the death of 99.99% of cells. High persistence was only observed when the lag phase was long enough to induce carbon starvation, consistent with the ppGpp accumulation kinetics (<xref ref-type="fig" rid="fig2">Figures 2C</xref>&#x2013;<xref ref-type="fig" rid="fig2">G</xref>).</p>
<fig position="float" id="fig3">
<label>Figure 3</label>
<caption>
<p>ppGpp mediates higher persistence via inhibiting phospholipid synthesis. <bold>(A)</bold> Nutrient shift persister experimental procedure of reducing ppGpp accumulation time by adjusting pre-shift FadD level. <bold>(B)</bold> Time&#x2013;kill curves of different pre-shift FadD levels after a glucose to ampicillin containing oleic acid shift. <bold>(C)</bold> Persister level of overexpression strains at 24&#x202F;h after a glucose to ampicillin containing oleic acid shift. Statistical results in <bold>(B,C)</bold> were calculated using a one-way ANOVA method with Dunnett&#x2019;s test of 24&#x202F;h survival rates. Intracellular ppGpp level quantified with HPLC at different time points of nutrient downshift from glucose to ampicillin-containing oleic acid of <italic>aas<sup>+</sup></italic> <bold>(D)</bold> and <italic>plsB<sup>+</sup></italic> <bold>(E)</bold> mutant strain. <bold>(F)</bold> Proposed ppGpp-dependent persister formation mechanism following the nutrient shift from glucose to oleic acid in the presence of ampicillin. Statistical results in <bold>(D,E)</bold> were calculated using a one-way ANOVA method with Dunnett&#x2019;s test.</p>
</caption>
<graphic xlink:href="fmicb-16-1749456-g003.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Panel A presents a diagram depicting modified persister experimental procedures to adjust FadD level before shift. (B) Line graph showing log-fold survival for different pre-shift FadD levels. (C) Line graph of log fold survival for different mutants. (D) Bar graph of ppGpp concentration over time for wild-type vs. Aas overexpression strain. (E) Bar graph of ppGpp concentration over time for wild-type vs. PlsB overexpression strains. (F) Proposed ppGpp-mediated persister formation mechanism.</alt-text>
</graphic>
</fig>
<p>We next hypothesized that FA starvation drives ppGpp accumulation through holo-ACP. After the GLU&#x202F;&#x2192;&#x202F;OA&#x202F;+&#x202F;AMP shift, FA degradation is activated while FA biosynthesis is repressed by FadR and FabR (<xref ref-type="bibr" rid="ref41">My et al., 2015</xref>). Repression of FA biosynthesis depletes acyl-ACP and holo-ACP pool size relatively increases. Unacylated holo-ACP then activates the ppGpp synthase activity of SpoT, while reducing its hydrolase activity (<xref ref-type="bibr" rid="ref10">Battesti and Bouveret, 2006</xref>; <xref ref-type="bibr" rid="ref6">Angelini et al., 2012</xref>; <xref ref-type="bibr" rid="ref20">Fern&#x00E1;ndez-Coll and Cashel, 2020</xref>), thereby driving ppGpp accumulation. Elevated ppGpp further amplifies the effect by inhibiting FA biosynthesis enzymes, thus forming a positive feedback loop. To test this, we overexpressed the <italic>E. coli</italic> acyl-ACP synthetase (encoded by <italic>aas</italic>), which ligates free FAs to holo-ACP, regenerating acyl-ACP (<xref ref-type="bibr" rid="ref30">Jackowski et al., 1994</xref>). We performed GLU&#x202F;&#x2192;&#x202F;OA&#x202F;+&#x202F;AMP shift and time-kill assays using the <italic>aas</italic> overexpression strain (<xref ref-type="fig" rid="fig3">Figure 3C</xref>, <italic>aas<sup>+</sup></italic>), and quantified the ppGpp concentration with HPLC. <italic>Aas</italic><sup>+</sup> mutant strain showed a trend of reduced ppGpp accumulation at 3&#x202F;h and, more notably, failed to sustain the elevated level seen in the WT at later time points, consistent with acyl-ACP synthetase restoring acyl-ACP as imported FAs accumulated overtime (<xref ref-type="fig" rid="fig3">Figure 3D</xref>) (<xref ref-type="bibr" rid="ref30">Jackowski et al., 1994</xref>). This reduced ppGpp allowed growth to resume, leading to rapid antibiotic killing. Consistently, the time-kill assay revealed a substantially reduced persistence observed in the <italic>aas<sup>+</sup></italic> strain, with 95% cells killed after 24&#x202F;h, compared to 44% in the wildtype strain. As a negative control, overexpression of green fluorescent protein (GFP) from the same promoter showed no effect on persistence (<xref ref-type="fig" rid="fig3">Figure 3C</xref>, <italic>gfp</italic><sup>+</sup>), ruling out the possibility of vector and protein overexpression-induced differences. We further hypothesized that ppGpp promotes persister formation in wildtype <italic>E. coli</italic> by inhibiting PlsB, the sn-glycerol-3-phosphate acyltransferase that catalyzes the first committed step of phospholipid biosynthesis (<xref ref-type="bibr" rid="ref27">Heath et al., 1994</xref>; <xref ref-type="bibr" rid="ref56">Yao and Rock, 2013</xref>). To test so, we constructed a <italic>plsB</italic> overexpression mutant (<italic>plsB<sup>+</sup></italic>) to alleviate ppGpp inhibition through increasing the enzyme copy number. We found that the <italic>plsB<sup>+</sup></italic> strain displayed reduced persistence, with 97% cells killed after 24&#x202F;h in OA&#x202F;+&#x202F;AMP (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). HPLC results showed that ppGpp kinetics in <italic>plsB+</italic> (<xref ref-type="fig" rid="fig3">Figure 3E</xref>) largely matched with that in wildtype. Thus, excess PlsB likely enabled continued phospholipid synthesis despite ppGpp, accelerating recovery and antibiotic killing. Finally, overexpressing both <italic>aas</italic> and <italic>plsB</italic> (<italic>aas-plsB</italic><sup>+</sup>) did not further decrease persistence beyond single overexpression (~97.6% killed, <xref ref-type="fig" rid="fig3">Figure 3C</xref>). This lack of synergy is likely due to the metabolic coupling: PlsB consumes acyl-ACP, the product of acyl-ACP synthetase, regenerating holo-ACP and offsetting the effect on ppGpp (<xref ref-type="fig" rid="fig3">Figure 3F</xref>).</p>
</sec>
<sec id="sec16">
<title>Metabolism changes in persisters formed after GLU&#x202F;&#x2192;&#x202F;OA&#x202F;+&#x202F;AMP nutrient downshift</title>
<p>At last, we sought to understand whether persisters formed after the GLU&#x202F;&#x2192;&#x202F;OA&#x202F;+&#x202F;AMP shift remains metabolic activity or enter complete dormancy. To examine amino acid and protein synthesis, we performed GLU&#x202F;&#x2192;&#x202F;OA&#x202F;+&#x202F;AMP shift using unlabeled (<sup>12</sup>C) glucose and fully <sup>13</sup>C-labeled OA. Cells were harvested at 5, 9, and 24&#x202F;h post-shift, with 5&#x202F;h representing the end of the transient tolerance phase and the last two time points within the persistence window. Total proteins were extracted, hydrolyzed into amino acids, and analyzed via GC-MS (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). At 5&#x202F;h post-shift, <sup>13</sup>C incorporation into proteinogenic amino acids was minimal, indicating very low flux into amino acid biosynthesis, consistent with the lack of FA catabolism due to insufficient &#x03B2;-oxidation enzymes. By 9&#x202F;h, elevated <sup>13</sup>C enrichment was detected across all measured amino acids. These results demonstrates that carbon derived from &#x03B2;-oxidation entered central pathways for amino acid and protein biosynthesis, confirming that persisters remained metabolically active rather than fully dormant during persistence (<xref ref-type="bibr" rid="ref12">Blattman et al., 2024</xref>; <xref ref-type="bibr" rid="ref22">Fung et al., 2025</xref>). The <sup>13</sup>C incorporation involves &#x03B2;-oxidation to acetyl-CoA, the TCA cycle, gluconeogenesis, and the pentose phosphate pathway (e.g., valine and histidine, <xref ref-type="fig" rid="fig4">Figure 4A</xref>). Additional <sup>13</sup>C incorporation continued beyond 9&#x202F;h, but at a slower rate, reflecting emerging metabolic bottlenecks despite substrate availability.</p>
<fig position="float" id="fig4">
<label>Figure 4</label>
<caption>
<p>Bacterial persister metabolism during nutrient downshift from glucose to oleic acid. <bold>(A)</bold> Metabolic pathways involved in nutrient downshift from glucose to ampicillin-containing oleic acid shift. <bold>(B)</bold> <sup>13</sup>C labeled proteinogenic amino acid enrichment at 5&#x202F;h, 9&#x202F;h, and 24&#x202F;h after nutrient shift from <sup>12</sup>C-glucose to fully labeled <sup>13</sup>C -oleic acid along with ampicillin. <bold>(C)</bold> Key metabolite relative abundance after nutrient shift from glucose to ampicillin-containing oleic acid to that of cells exponentially growing on glucose. SUC, Succinate; MAL, Malate; S7P, Sedoheptulose 7-phosphate; 2PG, 2-Phosphoglycerate; FBP, Fructose 1,6-biphosphate.</p>
</caption>
<graphic xlink:href="fmicb-16-1749456-g004.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Diagram depicting metabolic pathways and data visualizations. Panel A shows a glycolysis and TCA cycle pathway with substrates and intermediate compounds. Amino acids are marked in red. Panel B is a heatmap of amino acid abundance over time at 5, 9, and 24 hours, with darker shades indicating higher levels. Panel C is a bar graph showing the relative abundance of metabolites SUC, MAL, S7P, 2PG, and FBP at 5, 9, and 24 hours. Upregulated and downregulated annotations are included.</alt-text>
</graphic>
</fig>
<p>To further examine metabolic activity, we quantified intracellular metabolite pools using LC&#x2013;MS and compared them to exponentially growing glucose culture (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). Substantial changes were observed across key metabolites, marked by the depletion of malate, 2-phosphoglycerate (2PG), and fructose 1,6-bisphosphate (FBP), alongside the accumulation of succinate and sedoheptulose 7-phosphate (S7P). This signature reflects a defined metabolic strategy to cope with stress and indicates potential bottlenecks for growth resumption.</p>
<p>The depletion of FBP and 2PG confirms switch away from glucose catabolism and relief of inhibition on gluconeogenesis, allowing reverse flux from TCA intermediate up to gluconeogenesis. The sharp reduction in malate, despite abundant succinate, suggests its rapid conversion to oxaloacetate or pyruvate. Meanwhile, the significantly elevated S7P abundance indicates an active pentose phosphate pathway (PPP) activity. This metabolic shift represents a key adaptive response, as ampicillin treatment induces oxidative stress as part of lethality (<xref ref-type="bibr" rid="ref17">Dwyer et al., 2014</xref>; <xref ref-type="bibr" rid="ref60">Zhang et al., 2024</xref>). To survive, persister cells must detoxify reactive oxygen species (ROS) and maintain essential redox homeostasis. Channeling carbon flux through the PPP serves as a critical survival strategy to meet this demand, as it generates the NADPH required for antioxidant defense and redox balance under antibiotic pressure. The accumulation of S7P also suggests a persister state, as ppGpp shuts down the expensive DNA and RNA synthesis, which reduces the demand for nucleotides building block, ribose 5-phosphate (R5P), and as a result, leads to the accumulation of S7P. This metabolic reprogramming trend is consistent with the ppGpp-dependent transcriptional response profile observed during amino acid starvation (<xref ref-type="bibr" rid="ref49">Traxler et al., 2008</xref>). Together, these results show that persisters after the GLU&#x202F;&#x2192;&#x202F;OA&#x202F;+&#x202F;AMP shift undergo active carbon flux reprogramming rather than metabolic shutdown. Activation of gluconeogenesis and the pentose phosphate pathway provide a survival strategy to balance redox homeostasis and counter oxidative stress, thereby enabling persistence and evasion of &#x03B2;-lactam killing (<xref ref-type="bibr" rid="ref34">Kawai et al., 2019</xref>).</p>
</sec>
</sec>
<sec sec-type="discussion" id="sec17">
<title>Discussion</title>
<p>This work identifies the GLU&#x202F;&#x2192;&#x202F;OA nutrient shift as a unique trigger of <italic>E. coli</italic> persistence against &#x03B2;-lactams and aminoglycosides. The central determinant of this phenomenon is ppGpp. Real-time biosensing and HPLC quantification both revealed that ppGpp rises sharply during the prolonged lag phase that follows the GLU&#x202F;&#x2192;&#x202F;OA&#x202F;+&#x202F;AMP switch, but not during other nutrient shifts. Manipulations that shorten starvation or lower ppGpp accumulation via acyl-ACP synthase overexpression reduced persistence, directly linking FA starvation and elevated ppGpp level with antibiotic persistence. Mechanistically, our results suggest that following the GLU&#x202F;&#x2192;&#x202F;OA&#x202F;+&#x202F;AMP shift, FA catabolism represses FA biosynthesis, depleting acyl-ACP, which in turn stimulates SpoT-mediated ppGpp synthesis. Elevated ppGpp can inhibit transcription of <italic>fabH</italic> and other FA biosynthesis genes (43, 44), while also suppressing phospholipid synthesis through inhibition of PlsB enzyme activity. The combined effect halts cell growth and promotes antibiotic tolerance. Overexpression of <italic>aas</italic> reduced ppGpp levels while overexpression of <italic>plsB</italic> alleviate the inhibition of membrane biosynthesis, both leading to reduced persistence and supporting the central role of FA&#x2013;ppGpp coupling in persister formation.</p>
<p>Stable isotope tracing and metabolomics further demonstrate that persisters triggered by GLU&#x202F;&#x2192;&#x202F;OA&#x202F;+&#x202F;AMP shift are not metabolically inert. Instead, they actively channel carbon from FA through &#x03B2;-oxidation, the TCA cycle, gluconeogenesis, and the pentose phosphate pathway. This flux reprogramming sustains redox balance, supports limited biosynthesis, and helps cells withstand ROS. These observations highlight persistence as a metabolically adaptive, rather than dormant state, under our experimental conditions.</p>
<p>These findings contribute to our understanding of bacterial persistence. They show that metabolic shift can program persistence through defined regulatory and metabolic pathways (<xref ref-type="bibr" rid="ref44">Schmitz et al., 2017</xref>; <xref ref-type="bibr" rid="ref18">Evans and Zhang, 2020</xref>). By revealing how nutrient downshifts couple FA metabolism, ppGpp signaling, and redox-protective fluxes, this work highlights new vulnerabilities: targeting ppGpp synthesis indirectly via acyl-ACP balance or forcing metabolic bottlenecks open with metabolite supplementation may collapse persistence and restore antibiotic efficacy. More broadly, our study illustrates how environmental nutrient transitions, prevalent in host niches, can remodel bacterial physiology to promote survival under antibiotic stress. Given that many molecular pathways regulating stress responses, toxin-antitoxin systems, metabolism, and survival are conserved among bacteria, this insight not only deepens the mechanistic understanding of persistence but also reinforces metabolic interventions as a new front in the fight against recurrent and recalcitrant infections (<xref ref-type="bibr" rid="ref3">Allison et al., 2011b</xref>).</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="sec18">
<title>Data availability statement</title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/<xref rid="SM1" ref-type="supplementary-material">Supplementary material</xref>.</p>
</sec>
<sec sec-type="author-contributions" id="sec19">
<title>Author contributions</title>
<p>RZ: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Software, Validation, Visualization, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. ZX: Data curation, Writing &#x2013; review &#x0026; editing. NN: Data curation, Writing &#x2013; review &#x0026; editing. YT: Formal analysis, Funding acquisition, Resources, Supervision, Writing &#x2013; review &#x0026; editing. JY: Resources, Writing &#x2013; review &#x0026; editing. FZ: Conceptualization, Formal analysis, Funding acquisition, Project administration, Resources, Supervision, Writing &#x2013; review &#x0026; editing.</p>
</sec>
<sec sec-type="COI-statement" id="sec20">
<title>Conflict of interest</title>
<p>The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="ai-statement" id="sec21">
<title>Generative AI statement</title>
<p>The author(s) declared that generative AI was not used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec sec-type="disclaimer" id="sec22">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec sec-type="supplementary-material" id="sec23">
<title>Supplementary material</title>
<p>The Supplementary material for this article can be found online at: <ext-link xlink:href="https://www.frontiersin.org/articles/10.3389/fmicb.2025.1749456/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fmicb.2025.1749456/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Video_1.MP4" id="SM1" mimetype="video/mp4" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Video_2.MOV" id="SM2" mimetype="video/quicktime" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Video_3.MP4" id="SM3" mimetype="video/mp4" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Video_4.MP4" id="SM4" mimetype="video/mp4" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Video_5.MP4" id="SM5" mimetype="video/mp4" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Data_Sheet_1.XLSX" id="SM6" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Data_Sheet_2.DOCX" id="SM7" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="ref1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahn-Horst</surname><given-names>T. A.</given-names></name> <name><surname>Mille</surname><given-names>L. S.</given-names></name> <name><surname>Sun</surname><given-names>G.</given-names></name> <name><surname>Morrison</surname><given-names>J. H.</given-names></name> <name><surname>Covert</surname><given-names>M. W.</given-names></name></person-group> (<year>2022</year>). <article-title>An expanded whole-cell model of <italic>E. coli</italic> links cellular physiology with mechanisms of growth rate control</article-title>. <source>NPJ Syst. Biol. Appl.</source> <volume>8</volume>:<fpage>30</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41540-022-00242-9</pub-id></mixed-citation></ref>
<ref id="ref2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allison</surname><given-names>K. R.</given-names></name> <name><surname>Brynildsen</surname><given-names>M. P.</given-names></name> <name><surname>Collins</surname><given-names>J. J.</given-names></name></person-group> (<year>2011a</year>). <article-title>Heterogeneous bacterial persisters and engineering approaches to eliminate them</article-title>. <source>Curr. Opin. Microbiol.</source> <volume>14</volume>, <fpage>593</fpage>&#x2013;<lpage>598</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.mib.2011.09.002</pub-id></mixed-citation></ref>
<ref id="ref3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allison</surname><given-names>K. R.</given-names></name> <name><surname>Brynildsen</surname><given-names>M. P.</given-names></name> <name><surname>Collins</surname><given-names>J. J.</given-names></name></person-group> (<year>2011b</year>). <article-title>Metabolite-enabled eradication of bacterial persisters by aminoglycosides</article-title>. <source>Nature</source> <volume>473</volume>, <fpage>216</fpage>&#x2013;<lpage>220</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nature10069</pub-id></mixed-citation></ref>
<ref id="ref4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amato</surname><given-names>S. M.</given-names></name> <name><surname>Brynildsen</surname><given-names>M. P.</given-names></name></person-group> (<year>2015</year>). <article-title>Persister heterogeneity arising from a single metabolic stress</article-title>. <source>Curr. Biol.</source> <volume>25</volume>, <fpage>2090</fpage>&#x2013;<lpage>2098</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cub.2015.06.034</pub-id>, <pub-id pub-id-type="pmid">26255847</pub-id></mixed-citation></ref>
<ref id="ref5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amato</surname><given-names>S. M.</given-names></name> <name><surname>Orman</surname><given-names>M. A.</given-names></name> <name><surname>Brynildsen</surname><given-names>M. P.</given-names></name></person-group> (<year>2013</year>). <article-title>Metabolic control of persister formation in <italic>Escherichia coli</italic></article-title>. <source>Mol. Cell</source> <volume>50</volume>, <fpage>475</fpage>&#x2013;<lpage>487</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.molcel.2013.04.002</pub-id>, <pub-id pub-id-type="pmid">23665232</pub-id></mixed-citation></ref>
<ref id="ref6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angelini</surname><given-names>S.</given-names></name> <name><surname>My</surname><given-names>L.</given-names></name> <name><surname>Bouveret</surname><given-names>E.</given-names></name></person-group> (<year>2012</year>). <article-title>Disrupting the acyl carrier protein/SpoT interaction in vivo: identification of ACP residues involved in the interaction and consequence on growth</article-title>. <source>PLoS One</source> <volume>7</volume>:<fpage>e36111</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0036111</pub-id>, <pub-id pub-id-type="pmid">22558350</pub-id></mixed-citation></ref>
<ref id="ref7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bakkeren</surname><given-names>E.</given-names></name> <name><surname>Diard</surname><given-names>M.</given-names></name> <name><surname>Hardt</surname><given-names>W.-D.</given-names></name></person-group> (<year>2020</year>). <article-title>Evolutionary causes and consequences of bacterial antibiotic persistence</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>18</volume>, <fpage>479</fpage>&#x2013;<lpage>490</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41579-020-0378-z</pub-id>, <pub-id pub-id-type="pmid">32461608</pub-id></mixed-citation></ref>
<ref id="ref8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balaban</surname><given-names>N. Q.</given-names></name> <name><surname>Merrin</surname><given-names>J.</given-names></name> <name><surname>Chait</surname><given-names>R.</given-names></name> <name><surname>Kowalik</surname><given-names>L.</given-names></name> <name><surname>Leibler</surname><given-names>S.</given-names></name></person-group> (<year>2004</year>). <article-title>Bacterial persistence as a phenotypic switch</article-title>. <source>Science</source> <volume>305</volume>, <fpage>1622</fpage>&#x2013;<lpage>1625</lpage>. doi: <pub-id pub-id-type="doi">10.1126/science.1099390</pub-id>, <pub-id pub-id-type="pmid">15308767</pub-id></mixed-citation></ref>
<ref id="ref9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balsalobre</surname><given-names>C.</given-names></name></person-group> (<year>2011</year>). <article-title>Concentration matters&#x203C; ppGpp, from a whispering to a strident alarmone</article-title>. <source>Mol. Microbiol.</source> <volume>79</volume>, <fpage>827</fpage>&#x2013;<lpage>829</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1365-2958.2010.07521.x</pub-id>, <pub-id pub-id-type="pmid">21299641</pub-id></mixed-citation></ref>
<ref id="ref10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Battesti</surname><given-names>A.</given-names></name> <name><surname>Bouveret</surname><given-names>E.</given-names></name></person-group> (<year>2006</year>). <article-title>Acyl carrier protein/SpoT interaction, the switch linking SpoT-dependent stress response to fatty acid metabolism</article-title>. <source>Mol. Microbiol.</source> <volume>62</volume>, <fpage>1048</fpage>&#x2013;<lpage>1063</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1365-2958.2006.05442.x</pub-id>, <pub-id pub-id-type="pmid">17078815</pub-id></mixed-citation></ref>
<ref id="ref11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biselli</surname><given-names>E.</given-names></name> <name><surname>Schink</surname><given-names>S. J.</given-names></name> <name><surname>Gerland</surname><given-names>U.</given-names></name></person-group> (<year>2020</year>). <article-title>Slower growth of <italic>Escherichia coli</italic> leads to longer survival in carbon starvation due to a decrease in the maintenance rate</article-title>. <source>Mol. Syst. Biol.</source> <volume>16</volume>:<fpage>e9478</fpage>. doi: <pub-id pub-id-type="doi">10.15252/msb.20209478</pub-id></mixed-citation></ref>
<ref id="ref12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blattman</surname><given-names>S. B.</given-names></name> <name><surname>Jiang</surname><given-names>W.</given-names></name> <name><surname>McGarrigle</surname><given-names>E. R.</given-names></name> <name><surname>Liu</surname><given-names>M.</given-names></name> <name><surname>Oikonomou</surname><given-names>P.</given-names></name> <name><surname>Tavazoie</surname><given-names>S.</given-names></name></person-group> (<year>2024</year>). <article-title>Identification and genetic dissection of convergent persister cell states</article-title>. <source>Nature</source> <volume>636</volume>, <fpage>438</fpage>&#x2013;<lpage>446</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41586-024-08124-2</pub-id>, <pub-id pub-id-type="pmid">39506104</pub-id></mixed-citation></ref>
<ref id="ref13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brauner</surname><given-names>A.</given-names></name> <name><surname>Fridman</surname><given-names>O.</given-names></name> <name><surname>Gefen</surname><given-names>O.</given-names></name> <name><surname>Balaban</surname><given-names>N. Q.</given-names></name></person-group> (<year>2016</year>). <article-title>Distinguishing between resistance, tolerance and persistence to antibiotic treatment</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>14</volume>, <fpage>320</fpage>&#x2013;<lpage>330</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nrmicro.2016.34</pub-id>, <pub-id pub-id-type="pmid">27080241</pub-id></mixed-citation></ref>
<ref id="ref14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cabodevilla</surname><given-names>A. G.</given-names></name> <name><surname>S&#x00E1;nchez-Caballero</surname><given-names>L.</given-names></name> <name><surname>Nintou</surname><given-names>E.</given-names></name> <name><surname>Boiadjieva</surname><given-names>V. G.</given-names></name> <name><surname>Picatoste</surname><given-names>F.</given-names></name> <name><surname>Gubern</surname><given-names>A.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Cell survival during complete nutrient deprivation depends on lipid droplet-fueled &#x03B2;-oxidation of fatty acids</article-title>. <source>J. Biol. Chem.</source> <volume>288</volume>, <fpage>27777</fpage>&#x2013;<lpage>27788</lpage>. doi: <pub-id pub-id-type="doi">10.1074/jbc.M113.466656</pub-id>, <pub-id pub-id-type="pmid">23940052</pub-id></mixed-citation></ref>
<ref id="ref15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conway</surname><given-names>T.</given-names></name> <name><surname>Krogfelt</surname><given-names>K. A.</given-names></name> <name><surname>Cohen</surname><given-names>P. S.</given-names></name></person-group> (<year>2004</year>). <article-title>The life of commensal <italic>Escherichia coli</italic> in the mammalian intestine</article-title>. <source>EcoSal Plus</source> <volume>1</volume>: <fpage>1</fpage>&#x2013;<lpage>16</lpage>. doi: <pub-id pub-id-type="doi">10.1128/ecosalplus.8.3.1.2</pub-id></mixed-citation></ref>
<ref id="ref16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Czech</surname><given-names>L.</given-names></name> <name><surname>Mais</surname><given-names>C.-N.</given-names></name> <name><surname>Kratzat</surname><given-names>H.</given-names></name> <name><surname>Sarmah</surname><given-names>P.</given-names></name> <name><surname>Giammarinaro</surname><given-names>P.</given-names></name> <name><surname>Freibert</surname><given-names>S.-A.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>Inhibition of SRP-dependent protein secretion by the bacterial alarmone (p)ppGpp</article-title>. <source>Nat. Commun.</source> <volume>13</volume>:<fpage>1069</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-022-28675-0</pub-id></mixed-citation></ref>
<ref id="ref17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dwyer</surname><given-names>D. J.</given-names></name> <name><surname>Belenky</surname><given-names>P. A.</given-names></name> <name><surname>Yang</surname><given-names>J. H.</given-names></name> <name><surname>MacDonald</surname><given-names>I. C.</given-names></name> <name><surname>Martell</surname><given-names>J. D.</given-names></name> <name><surname>Takahashi</surname><given-names>N.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>Antibiotics induce redox-related physiological alterations as part of their lethality</article-title>. <source>Proc. Natl. Acad. Sci.</source> <volume>111</volume>, <fpage>E2100</fpage>&#x2013;<lpage>E2109</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.1401876111</pub-id>, <pub-id pub-id-type="pmid">24803433</pub-id></mixed-citation></ref>
<ref id="ref18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>T. D.</given-names></name> <name><surname>Zhang</surname><given-names>F.</given-names></name></person-group> (<year>2020</year>). <article-title>Bacterial metabolic heterogeneity: origins and applications in engineering and infectious disease</article-title>. <source>Curr. Opin. Biotechnol.</source> <volume>64</volume>, <fpage>183</fpage>&#x2013;<lpage>189</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.copbio.2020.04.007</pub-id>, <pub-id pub-id-type="pmid">32574927</pub-id></mixed-citation></ref>
<ref id="ref19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>X.</given-names></name> <name><surname>Allison</surname><given-names>K. R.</given-names></name></person-group> (<year>2023</year>). <article-title>Resuscitation dynamics reveal persister partitioning after antibiotic treatment</article-title>. <source>Mol. Syst. Biol.</source> <volume>19</volume>:<fpage>e11320</fpage>. doi: <pub-id pub-id-type="doi">10.15252/msb.202211320</pub-id>, <pub-id pub-id-type="pmid">36866643</pub-id></mixed-citation></ref>
<ref id="ref20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fern&#x00E1;ndez-Coll</surname><given-names>L.</given-names></name> <name><surname>Cashel</surname><given-names>M.</given-names></name></person-group> (<year>2020</year>). <article-title>Possible roles for basal levels of (p)ppGpp: growth efficiency vs. surviving stress</article-title>. <source>Front. Microbiol.</source> <volume>11</volume>:<fpage>592718</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2020.592718</pub-id>, <pub-id pub-id-type="pmid">33162969</pub-id></mixed-citation></ref>
<ref id="ref21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fisher</surname><given-names>R. A.</given-names></name> <name><surname>Gollan</surname><given-names>B.</given-names></name> <name><surname>Helaine</surname><given-names>S.</given-names></name></person-group> (<year>2017</year>). <article-title>Persistent bacterial infections and persister cells</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>15</volume>, <fpage>453</fpage>&#x2013;<lpage>464</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nrmicro.2017.42</pub-id>, <pub-id pub-id-type="pmid">28529326</pub-id></mixed-citation></ref>
<ref id="ref22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fung</surname><given-names>D. K.</given-names></name> <name><surname>Barra</surname><given-names>J. T.</given-names></name> <name><surname>Yang</surname><given-names>J.</given-names></name> <name><surname>Schroeder</surname><given-names>J. W.</given-names></name> <name><surname>She</surname><given-names>F.</given-names></name> <name><surname>Young</surname><given-names>M.</given-names></name> <etal/></person-group>. (<year>2025</year>). <article-title>A shared alarmone&#x2013;GTP switch controls persister formation in bacteria</article-title>. <source>Nat. Microbiol.</source> <volume>10</volume>, <fpage>1617</fpage>&#x2013;<lpage>1629</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41564-025-02015-6</pub-id>, <pub-id pub-id-type="pmid">40374742</pub-id></mixed-citation></ref>
<ref id="ref23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>H.</given-names></name> <name><surname>Song</surname><given-names>Y.</given-names></name> <name><surname>Li</surname><given-names>M.</given-names></name> <name><surname>Gao</surname><given-names>M.</given-names></name> <name><surname>Peng</surname><given-names>Z.</given-names></name> <name><surname>Pan</surname><given-names>H.</given-names></name> <etal/></person-group>. (<year>2025</year>). <article-title>Nutrient availability shapes the resistance of soil bacterial community and functions to disturbances in desert ecosystem</article-title>. <source>Environ. Microbiol.</source> <volume>27</volume>:<fpage>e70081</fpage>. doi: <pub-id pub-id-type="doi">10.1111/1462-2920.70081</pub-id>, <pub-id pub-id-type="pmid">40077807</pub-id></mixed-citation></ref>
<ref id="ref24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>Y.</given-names></name> <name><surname>Zhang</surname><given-names>F.</given-names></name></person-group> (<year>2020</year>). <article-title>Heterogeneity coordinates bacterial multi-gene expression in single cells</article-title>. <source>PLoS Comput. Biol.</source> <volume>16</volume>:<fpage>e1007643</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pcbi.1007643</pub-id></mixed-citation></ref>
<ref id="ref25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartline</surname><given-names>C. J.</given-names></name> <name><surname>Mannan</surname><given-names>A. A.</given-names></name> <name><surname>Liu</surname><given-names>D.</given-names></name> <name><surname>Zhang</surname><given-names>F.</given-names></name> <name><surname>Oyarz&#x00FA;n</surname><given-names>D. A.</given-names></name></person-group> (<year>2020</year>). <article-title>Metabolite sequestration enables rapid recovery from fatty acid depletion in <italic>Escherichia coli</italic></article-title>. <source>mBio</source> <volume>11</volume>, <fpage>e03112</fpage>&#x2013;<lpage>e03119</lpage>. doi: <pub-id pub-id-type="doi">10.1128/mBio.03112-19</pub-id></mixed-citation></ref>
<ref id="ref26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartline</surname><given-names>C. J.</given-names></name> <name><surname>Zhang</surname><given-names>R.</given-names></name> <name><surname>Zhang</surname><given-names>F.</given-names></name></person-group> (<year>2022</year>). <article-title>Transient antibiotic tolerance triggered by nutrient shifts from gluconeogenic carbon sources to fatty acid</article-title>. <source>Front. Microbiol.</source> <volume>13</volume>:<fpage>854272</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2022.854272</pub-id>, <pub-id pub-id-type="pmid">35359720</pub-id></mixed-citation></ref>
<ref id="ref27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heath</surname><given-names>R. J.</given-names></name> <name><surname>Jackowski</surname><given-names>S.</given-names></name> <name><surname>Rock</surname><given-names>C. O.</given-names></name></person-group> (<year>1994</year>). <article-title>Guanosine tetraphosphate inhibition of fatty acid and phospholipid synthesis in <italic>Escherichia coli</italic> is relieved by overexpression of glycerol-3-phosphate acyltransferase (plsB)</article-title>. <source>J. Biol. Chem.</source> <volume>269</volume>, <fpage>26584</fpage>&#x2013;<lpage>26590</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0021-9258(18)47234-1</pub-id>, <pub-id pub-id-type="pmid">7929384</pub-id></mixed-citation></ref>
<ref id="ref28"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Hollinshead</surname><given-names>W.</given-names></name> <name><surname>He</surname><given-names>L.</given-names></name> <name><surname>Tang</surname><given-names>Y. J.</given-names></name></person-group> (<year>2019</year>). &#x201C;<article-title>13C-fingerprinting and metabolic flux analysis of bacterial metabolisms</article-title>&#x201D; in <source>Microbial metabolic engineering: methods and protocols</source>. eds. <person-group person-group-type="editor"><name><surname>Santos</surname><given-names>C. N. S.</given-names></name> <name><surname>Ajikumar</surname><given-names>P. K.</given-names></name></person-group> (<publisher-loc>New York, NY</publisher-loc>: <publisher-name>Springer</publisher-name>), <fpage>215</fpage>&#x2013;<lpage>230</lpage>.</mixed-citation></ref>
<ref id="ref29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hollinshead</surname><given-names>W. D.</given-names></name> <name><surname>Rodriguez</surname><given-names>S.</given-names></name> <name><surname>Martin</surname><given-names>H. G.</given-names></name> <name><surname>Wang</surname><given-names>G.</given-names></name> <name><surname>Baidoo</surname><given-names>E. E. K.</given-names></name> <name><surname>Sale</surname><given-names>K. L.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Examining <italic>Escherichia coli</italic> glycolytic pathways, catabolite repression, and metabolite channeling using &#x0394;pfk mutants</article-title>. <source>Biotechnol. Biofuels</source> <volume>9</volume>:<fpage>212</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13068-016-0630-y</pub-id></mixed-citation></ref>
<ref id="ref30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackowski</surname><given-names>S.</given-names></name> <name><surname>Jackson</surname><given-names>P. D.</given-names></name> <name><surname>Rock</surname><given-names>C. O.</given-names></name></person-group> (<year>1994</year>). <article-title>Sequence and function of the aas gene in <italic>Escherichia coli</italic></article-title>. <source>J. Biol. Chem.</source> <volume>269</volume>, <fpage>2921</fpage>&#x2013;<lpage>2928</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0021-9258(17)42029-1</pub-id>, <pub-id pub-id-type="pmid">8300626</pub-id></mixed-citation></ref>
<ref id="ref31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>Y.</given-names></name> <name><surname>Chen</surname><given-names>B.</given-names></name> <name><surname>Duan</surname><given-names>C.</given-names></name> <name><surname>Sun</surname><given-names>B.</given-names></name> <name><surname>Yang</surname><given-names>J.</given-names></name> <name><surname>Yang</surname><given-names>S.</given-names></name></person-group> (<year>2015</year>). <article-title>Multigene editing in the <italic>Escherichia coli</italic> genome via the CRISPR-Cas9 system</article-title>. <source>Appl. Environ. Microbiol.</source> <volume>81</volume>, <fpage>2506</fpage>&#x2013;<lpage>2514</lpage>. doi: <pub-id pub-id-type="doi">10.1128/AEM.04023-14</pub-id>, <pub-id pub-id-type="pmid">25636838</pub-id></mixed-citation></ref>
<ref id="ref32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>W.</given-names></name> <name><surname>Qiao</surname><given-names>J. B.</given-names></name> <name><surname>Bentley</surname><given-names>G. J.</given-names></name> <name><surname>Liu</surname><given-names>D.</given-names></name> <name><surname>Zhang</surname><given-names>F.</given-names></name></person-group> (<year>2017</year>). <article-title>Modular pathway engineering for the microbial production of branched-chain fatty alcohols</article-title>. <source>Biotechnol. Biofuels</source> <volume>10</volume>:<fpage>244</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13068-017-0936-4</pub-id></mixed-citation></ref>
<ref id="ref33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawai</surname><given-names>Y.</given-names></name> <name><surname>Kawai</surname><given-names>M.</given-names></name> <name><surname>Mackenzie</surname><given-names>E. S.</given-names></name> <name><surname>Dashti</surname><given-names>Y.</given-names></name> <name><surname>Kepplinger</surname><given-names>B.</given-names></name> <name><surname>Waldron</surname><given-names>K. J.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title>On the mechanisms of lysis triggered by perturbations of bacterial cell wall biosynthesis</article-title>. <source>Nat. Commun.</source> <volume>14</volume>:<fpage>4123</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-023-39723-8</pub-id></mixed-citation></ref>
<ref id="ref34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawai</surname><given-names>Y.</given-names></name> <name><surname>Mercier</surname><given-names>R.</given-names></name> <name><surname>Mickiewicz</surname><given-names>K.</given-names></name> <name><surname>Serafini</surname><given-names>A.</given-names></name> <name><surname>S&#x00F3;rio de Carvalho</surname><given-names>L. P.</given-names></name> <name><surname>Errington</surname><given-names>J.</given-names></name></person-group> (<year>2019</year>). <article-title>Crucial role for central carbon metabolism in the bacterial L-form switch and killing by &#x03B2;-lactam antibiotics</article-title>. <source>Nat. Microbiol.</source> <volume>4</volume>, <fpage>1716</fpage>&#x2013;<lpage>1726</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41564-019-0497-3</pub-id>, <pub-id pub-id-type="pmid">31285586</pub-id></mixed-citation></ref>
<ref id="ref35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H.</given-names></name> <name><surname>Kim</surname><given-names>J. H.</given-names></name> <name><surname>Cho</surname><given-names>H.</given-names></name> <name><surname>Ko</surname><given-names>K. S.</given-names></name></person-group> (<year>2022</year>). <article-title>Overexpression of a DNA methyltransferase increases persister cell formation in <italic>Acinetobacter baumannii</italic></article-title>. <source>Microbiol. Spectr.</source> <volume>10</volume>, <fpage>e02655</fpage>&#x2013;<lpage>e02622</lpage>. doi: <pub-id pub-id-type="doi">10.1128/spectrum.02655-22</pub-id></mixed-citation></ref>
<ref id="ref36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kohanski</surname><given-names>M. A.</given-names></name> <name><surname>Dwyer</surname><given-names>D. J.</given-names></name> <name><surname>Hayete</surname><given-names>B.</given-names></name> <name><surname>Lawrence</surname><given-names>C. A.</given-names></name> <name><surname>Collins</surname><given-names>J. J.</given-names></name></person-group> (<year>2007</year>). <article-title>A common mechanism of cellular death induced by bactericidal antibiotics</article-title>. <source>Cell</source> <volume>130</volume>, <fpage>797</fpage>&#x2013;<lpage>810</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2007.06.049</pub-id>, <pub-id pub-id-type="pmid">17803904</pub-id></mixed-citation></ref>
<ref id="ref37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kotte</surname><given-names>O.</given-names></name> <name><surname>Volkmer</surname><given-names>B.</given-names></name> <name><surname>Radzikowski</surname><given-names>J. L.</given-names></name> <name><surname>Heinemann</surname><given-names>M.</given-names></name></person-group> (<year>2014</year>). <article-title>Phenotypic bistability in <italic>Escherichia coli&#x2019;s</italic> central carbon metabolism</article-title>. <source>Mol. Syst. Biol.</source> <volume>10</volume>:<fpage>736</fpage>. doi: <pub-id pub-id-type="doi">10.15252/msb.20135022</pub-id></mixed-citation></ref>
<ref id="ref38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>T. S.</given-names></name> <name><surname>Krupa</surname><given-names>R. A.</given-names></name> <name><surname>Zhang</surname><given-names>F.</given-names></name> <name><surname>Hajimorad</surname><given-names>M.</given-names></name> <name><surname>Holtz</surname><given-names>W. J.</given-names></name> <name><surname>Prasad</surname><given-names>N.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>BglBrick vectors and datasheets: a synthetic biology platform for gene expression</article-title>. <source>J. Biol. Eng.</source> <volume>5</volume>:<fpage>12</fpage>. doi: <pub-id pub-id-type="doi">10.1186/1754-1611-5-12</pub-id></mixed-citation></ref>
<ref id="ref39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>K.</given-names></name></person-group> (<year>2007</year>). <article-title>Persister cells, dormancy and infectious disease</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>5</volume>, <fpage>48</fpage>&#x2013;<lpage>56</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nrmicro1557</pub-id>, <pub-id pub-id-type="pmid">17143318</pub-id></mixed-citation></ref>
<ref id="ref40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moyed</surname><given-names>H. S.</given-names></name> <name><surname>Bertrand</surname><given-names>K. P.</given-names></name></person-group> (<year>1983</year>). <article-title>hipA, a newly recognized gene of <italic>Escherichia coli</italic> K-12 that affects frequency of persistence after inhibition of murein synthesis</article-title>. <source>J. Bacteriol.</source> <volume>155</volume>, <fpage>768</fpage>&#x2013;<lpage>775</lpage>. doi: <pub-id pub-id-type="doi">10.1128/jb.155.2.768-775.1983</pub-id>, <pub-id pub-id-type="pmid">6348026</pub-id></mixed-citation></ref>
<ref id="ref41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>My</surname><given-names>L.</given-names></name> <name><surname>Ghandour Achkar</surname><given-names>N.</given-names></name> <name><surname>Viala</surname><given-names>J. P.</given-names></name> <name><surname>Bouveret</surname><given-names>E.</given-names></name></person-group> (<year>2015</year>). <article-title>Reassessment of the genetic regulation of fatty acid synthesis in <italic>Escherichia coli</italic>: global positive control by the dual functional regulator FadR</article-title>. <source>J. Bacteriol.</source> <volume>197</volume>, <fpage>1862</fpage>&#x2013;<lpage>1872</lpage>. doi: <pub-id pub-id-type="doi">10.1128/JB.00064-15</pub-id>, <pub-id pub-id-type="pmid">25802297</pub-id></mixed-citation></ref>
<ref id="ref42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niu</surname><given-names>H.</given-names></name> <name><surname>Gu</surname><given-names>J.</given-names></name> <name><surname>Zhang</surname><given-names>Y.</given-names></name></person-group> (<year>2024</year>). <article-title>Bacterial persisters: molecular mechanisms and therapeutic development</article-title>. <source>Sig. Transduct. Target. Ther.</source> <volume>9</volume>, <fpage>1</fpage>&#x2013;<lpage>32</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41392-024-01866-5</pub-id></mixed-citation></ref>
<ref id="ref43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radzikowski</surname><given-names>J. L.</given-names></name> <name><surname>Vedelaar</surname><given-names>S.</given-names></name> <name><surname>Siegel</surname><given-names>D.</given-names></name> <name><surname>Ortega</surname><given-names>&#x00C1;. D.</given-names></name> <name><surname>Schmidt</surname><given-names>A.</given-names></name> <name><surname>Heinemann</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Bacterial persistence is an active &#x03C3; <sup>S</sup> stress response to metabolic flux limitation</article-title>. <source>Mol. Syst. Biol.</source> <volume>12</volume>:<fpage>882</fpage>. doi: <pub-id pub-id-type="doi">10.15252/msb.20166998</pub-id></mixed-citation></ref>
<ref id="ref44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmitz</surname><given-names>A. C.</given-names></name> <name><surname>Hartline</surname><given-names>C. J.</given-names></name> <name><surname>Zhang</surname><given-names>F.</given-names></name></person-group> (<year>2017</year>). <article-title>Engineering microbial metabolite dynamics and heterogeneity</article-title>. <source>Biotechnol. J.</source> <volume>12</volume>:<fpage>1700422</fpage>. doi: <pub-id pub-id-type="doi">10.1002/biot.201700422</pub-id></mixed-citation></ref>
<ref id="ref45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spoering</surname><given-names>A. L.</given-names></name> <name><surname>Vuli&#x0107;</surname><given-names>M.</given-names></name> <name><surname>Lewis</surname><given-names>K.</given-names></name></person-group> (<year>2006</year>). <article-title>GlpD and PlsB participate in Persister cell formation in <italic>Escherichia coli</italic></article-title>. <source>J. Bacteriol.</source> <volume>188</volume>, <fpage>5136</fpage>&#x2013;<lpage>5144</lpage>. doi: <pub-id pub-id-type="doi">10.1128/jb.00369-06</pub-id></mixed-citation></ref>
<ref id="ref46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steinchen</surname><given-names>W.</given-names></name> <name><surname>Zegarra</surname><given-names>V.</given-names></name> <name><surname>Bange</surname><given-names>G.</given-names></name></person-group> (<year>2020</year>). <article-title>(p)ppGpp: magic modulators of bacterial physiology and metabolism</article-title>. <source>Front. Microbiol.</source> <volume>11</volume>:<fpage>2072</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2020.02072</pub-id>, <pub-id pub-id-type="pmid">33013756</pub-id></mixed-citation></ref>
<ref id="ref47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Y.</given-names></name> <name><surname>Roy</surname><given-names>S.</given-names></name> <name><surname>Yang</surname><given-names>Q.</given-names></name> <name><surname>Tang</surname><given-names>Y. J.</given-names></name> <name><surname>Ren</surname><given-names>D.</given-names></name></person-group> (<year>2025</year>). <article-title>Differential carbon source utilization drives metabolic state and resuscitation in antibiotic-tolerant persister cells</article-title>. <source>Front. Pharmacol.</source> <volume>16</volume>:<fpage>1634627</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fphar.2025.1634627</pub-id>, <pub-id pub-id-type="pmid">40969939</pub-id></mixed-citation></ref>
<ref id="ref48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Z.</given-names></name> <name><surname>Wu</surname><given-names>R.</given-names></name> <name><surname>Zhao</surname><given-names>B.</given-names></name> <name><surname>Zeinert</surname><given-names>R.</given-names></name> <name><surname>Chien</surname><given-names>P.</given-names></name> <name><surname>You</surname><given-names>M.</given-names></name></person-group> (<year>2021</year>). <article-title>Live-cell imaging of guanosine tetra- and pentaphosphate (p)ppGpp with RNA-based fluorescent sensors</article-title>. <source>Angew. Chem. Int. Ed.</source> <volume>60</volume>, <fpage>24070</fpage>&#x2013;<lpage>24074</lpage>. doi: <pub-id pub-id-type="doi">10.1002/anie.202111170</pub-id>, <pub-id pub-id-type="pmid">34487413</pub-id></mixed-citation></ref>
<ref id="ref49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Traxler</surname><given-names>M. F.</given-names></name> <name><surname>Summers</surname><given-names>S. M.</given-names></name> <name><surname>Nguyen</surname><given-names>H.-T.</given-names></name> <name><surname>Zacharia</surname><given-names>V. M.</given-names></name> <name><surname>Hightower</surname><given-names>G. A.</given-names></name> <name><surname>Smith</surname><given-names>J. T.</given-names></name> <etal/></person-group>. (<year>2008</year>). <article-title>The global, ppGpp-mediated stringent response to amino acid starvation in <italic>Escherichia coli</italic></article-title>. <source>Mol. Microbiol.</source> <volume>68</volume>, <fpage>1128</fpage>&#x2013;<lpage>1148</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1365-2958.2008.06229.x</pub-id>, <pub-id pub-id-type="pmid">18430135</pub-id></mixed-citation></ref>
<ref id="ref50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valencia</surname><given-names>E. Y.</given-names></name> <name><surname>de Moraes Gomes</surname><given-names>F.</given-names></name> <name><surname>Ospino</surname><given-names>K.</given-names></name> <name><surname>Spira</surname><given-names>B.</given-names></name></person-group> (<year>2024</year>). <article-title>RpoS role in antibiotic resistance, tolerance and persistence in <italic>E. coli</italic> natural isolates</article-title>. <source>BMC Microbiol.</source> <volume>24</volume>:<fpage>72</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12866-024-03222-7</pub-id></mixed-citation></ref>
<ref id="ref51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>V&#x00E1;zquez-Laslop</surname><given-names>N.</given-names></name> <name><surname>Lee</surname><given-names>H.</given-names></name> <name><surname>Neyfakh</surname><given-names>A. A.</given-names></name></person-group> (<year>2006</year>). <article-title>Increased persistence in <italic>Escherichia coli</italic> caused by controlled expression of toxins or other unrelated proteins</article-title>. <source>J. Bacteriol.</source> <volume>188</volume>, <fpage>3494</fpage>&#x2013;<lpage>3497</lpage>. doi: <pub-id pub-id-type="doi">10.1128/JB.188.10.3494-3497.2006</pub-id>, <pub-id pub-id-type="pmid">16672603</pub-id></mixed-citation></ref>
<ref id="ref52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vega</surname><given-names>N. M.</given-names></name> <name><surname>Allison</surname><given-names>K. R.</given-names></name> <name><surname>Khalil</surname><given-names>A. S.</given-names></name> <name><surname>Collins</surname><given-names>J. J.</given-names></name></person-group> (<year>2012</year>). <article-title>Signaling-mediated bacterial persister formation</article-title>. <source>Nat. Chem. Biol.</source> <volume>8</volume>, <fpage>431</fpage>&#x2013;<lpage>433</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nchembio.915</pub-id>, <pub-id pub-id-type="pmid">22426114</pub-id></mixed-citation></ref>
<ref id="ref53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volkmer</surname><given-names>B.</given-names></name> <name><surname>Heinemann</surname><given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>Condition-dependent cell volume and concentration of <italic>Escherichia coli</italic> to facilitate data conversion for systems biology modeling</article-title>. <source>PLoS One</source> <volume>6</volume>:<fpage>e23126</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0023126</pub-id>, <pub-id pub-id-type="pmid">21829590</pub-id></mixed-citation></ref>
<ref id="ref54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilmaerts</surname><given-names>D.</given-names></name> <name><surname>Govers</surname><given-names>S. K.</given-names></name> <name><surname>Michiels</surname><given-names>J.</given-names></name></person-group> (<year>2022</year>). <article-title>Assessing persister awakening dynamics following antibiotic treatment in <italic>E. coli</italic></article-title>. <source>STAR Protoc.</source> <volume>3</volume>:<fpage>101476</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.xpro.2022.101476</pub-id></mixed-citation></ref>
<ref id="ref55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Y.</given-names></name> <name><surname>Vuli&#x0107;</surname><given-names>M.</given-names></name> <name><surname>Keren</surname><given-names>I.</given-names></name> <name><surname>Lewis</surname><given-names>K.</given-names></name></person-group> (<year>2012</year>). <article-title>Role of oxidative stress in persister tolerance</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>56</volume>, <fpage>4922</fpage>&#x2013;<lpage>4926</lpage>. doi: <pub-id pub-id-type="doi">10.1128/AAC.00921-12</pub-id>, <pub-id pub-id-type="pmid">22777047</pub-id></mixed-citation></ref>
<ref id="ref56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>J.</given-names></name> <name><surname>Rock</surname><given-names>C. O.</given-names></name></person-group> (<year>2013</year>). <article-title>Phosphatidic acid synthesis in bacteria</article-title>. <source>Biochim. Biophys. Acta.</source> <volume>1831</volume>, <fpage>495</fpage>&#x2013;<lpage>502</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bbalip.2012.08.018</pub-id>, <pub-id pub-id-type="pmid">22981714</pub-id></mixed-citation></ref>
<ref id="ref57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>C.</given-names></name> <name><surname>Chen</surname><given-names>X.</given-names></name> <name><surname>Yang</surname><given-names>M.</given-names></name> <name><surname>Zeng</surname><given-names>X.</given-names></name> <name><surname>Qiao</surname><given-names>S.</given-names></name></person-group> (<year>2021</year>). <article-title>CRISPR/Cas9 mediated T7 RNA polymerase gene knock-in in <italic>E. coli</italic> BW25113 makes T7 expression system work efficiently</article-title>. <source>J. Biol. Eng.</source> <volume>15</volume>:<fpage>22</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13036-021-00270-9</pub-id></mixed-citation></ref>
<ref id="ref58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>S.</given-names></name> <name><surname>Shen</surname><given-names>Y.</given-names></name> <name><surname>Quan</surname><given-names>Y.</given-names></name> <name><surname>Gao</surname><given-names>S.</given-names></name> <name><surname>Zuo</surname><given-names>J.</given-names></name> <name><surname>Jin</surname><given-names>W.</given-names></name> <etal/></person-group>. (<year>2024</year>). <article-title>Molecular mechanism and application of emerging technologies in study of bacterial persisters</article-title>. <source>BMC Microbiol.</source> <volume>24</volume>:<fpage>480</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12866-024-03628-3</pub-id></mixed-citation></ref>
<ref id="ref59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y.</given-names></name></person-group> (<year>2014</year>). <article-title>Persisters, persistent infections and the Yin&#x2013;Yang model</article-title>. <source>Emerg. Microbes Infect.</source> <volume>3</volume>:<fpage>e3</fpage>. doi: <pub-id pub-id-type="doi">10.1038/emi.2014.3</pub-id></mixed-citation></ref>
<ref id="ref60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>R.</given-names></name> <name><surname>Hartline</surname><given-names>C.</given-names></name> <name><surname>Zhang</surname><given-names>F.</given-names></name></person-group> (<year>2024</year>). <article-title>The ability in managing reactive oxygen species affects <italic>Escherichia coli</italic> persistence to ampicillin after nutrient shifts</article-title>. <source>mSystems</source> <volume>9</volume>, <fpage>e01295</fpage>&#x2013;<lpage>e01224</lpage>. doi: <pub-id pub-id-type="doi">10.1128/msystems.01295-24</pub-id></mixed-citation></ref>
<ref id="ref61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>M.</given-names></name> <name><surname>Dai</surname><given-names>X.</given-names></name></person-group> (<year>2023</year>). <article-title>Stringent response ensures the timely adaptation of bacterial growth to nutrient downshift</article-title>. <source>Nat. Commun.</source> <volume>14</volume>:<fpage>467</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-023-36254-0</pub-id></mixed-citation></ref>
</ref-list>
<fn-group>
<fn fn-type="custom" custom-type="edited-by" id="fn0001">
<p>Edited by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/652500/overview">Katarzyna Potrykus</ext-link>, University of Gdansk, Poland</p>
</fn>
<fn fn-type="custom" custom-type="reviewed-by" id="fn0002">
<p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2526554/overview">Kavita De</ext-link>, Colorado State University, United States</p>
<p><ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/985486/overview">Danny K. Fung</ext-link>, University of Wisconsin-Madison, United States</p>
</fn>
</fn-group>
</back>
</article>